Clinical Trial Update: Gemcitabine in Treating Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine in patients with advanced colorectal cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED